Related Experiment Video
Updated: Feb 3, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet
Sarah M Skye1,2, Weifei Zhu1,2, Kymberleigh A Romano1,2,3
1From the Department of Cellular and Molecular Medicine, Lerner Research Institute (S.M.S., W.Z., K.A.R., Z.W., X.J., J.K., B.H., J.A.D., W.H.W.T., S.L.H.), Cleveland Clinic, OH.
Rationale:
Gut microbes influence cardiovascular disease and thrombosis risks through the production of trimethylamine N-oxide (TMAO). Microbiota-dependent generation of trimethylamine (TMA)-the precursor to TMAO-is rate limiting in the metaorganismal TMAO pathway in most humans and is catalyzed by several distinct microbial choline TMA-lyases, including the proteins encoded by the cutC/D (choline utilization C/D) genes in multiple human commensals.
Objective:
Direct demonstration that the gut microbial cutC gene is sufficient to transmit enhanced platelet reactivity and thrombosis potential in a host via TMA/TMAO generation has not yet been reported.
Methods And Results:
Herein, we use gnotobiotic mice and a series of microbial colonization studies to show that microbial cutC-dependent TMA/TMAO production is sufficient to transmit heightened platelet reactivity and thrombosis potential in a host. Specifically, we examine in vivo thrombosis potential employing germ-free mice colonized with either high TMA-producing stable human fecal polymcrobial communities or a defined CutC-deficient background microbial community coupled with a CutC-expressing human commensal±genetic disruption of its cutC gene (ie, Clostridium sporogenes Δ cutC).
Conclusions:
Collectively, these studies point to the microbial choline TMA-lyase pathway as a rational molecular target for the treatment of atherothrombotic heart disease.
Insights
The gut microbial cutC gene drives trimethylamine (TMA) production, increasing TMA-derived trimethylamine N-oxide (TMAO) levels. This microbial pathway enhances platelet reactivity and thrombosis risk, offering a target for heart disease treatment.
Area of Science:
- Microbiology
- Cardiovascular Science
- Metabolomics
Background:
- Gut microbes significantly impact cardiovascular disease and thrombosis risk via trimethylamine N-oxide (TMAO) production.
- Microbial generation of trimethylamine (TMA), the TMAO precursor, is a critical, rate-limiting step in this pathway.
- Specific microbial enzymes, like choline TMA-lyases encoded by cutC/D genes, catalyze TMA production in human commensals.
Purpose of the Study:
- To demonstrate that the gut microbial cutC gene is sufficient to transmit enhanced platelet reactivity and thrombosis potential to a host.
- To investigate the role of microbial cutC-dependent TMA/TMAO production in vivo.
Main Methods:
- Utilized gnotobiotic mice and microbial colonization studies.
- Compared thrombosis potential in germ-free mice colonized with high TMA-producing human fecal communities versus a defined CutC-deficient community.
- Examined the effect of a CutC-expressing commensal and its isogenic ΔcutC mutant (Clostridium sporogenes Δ cutC).
Main Results:
- Microbial cutC-dependent TMA/TMAO production was sufficient to transmit heightened platelet reactivity and thrombosis potential to the host.
- Colonization studies confirmed the direct link between microbial cutC activity and increased thrombosis risk.
Conclusions:
- The microbial choline TMA-lyase pathway, specifically involving the cutC gene, is a key mediator of TMA/TMAO-driven thrombosis.
- This pathway represents a rational molecular target for therapeutic intervention in atherothrombotic heart disease.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Sexually Transmitted Infections
Venous Thrombosis I: Introduction
Cross-reactivity
Reactivity of Enols
Microbial Fermentation
Microbial Morphologies